The Prospective Collection, Storage and Reporting of Data on Patients

Status: Recruiting
Location: See location...
Study Type: Observational [Patient Registry]
SUMMARY

To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: No
View:

• Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Locations
United States
North Carolina
Wake Forest Baptist Health
Recruiting
Winston-salem
Contact Information
Primary
Dianna Howard, MD
dhoward@wakehealth.edu
Time Frame
Start Date: May 21, 2001
Estimated Completion Date: May 2024
Participants
Target number of participants: 2000
Authors
Dianna Howard, David Hurd
Sponsors
Leads: Wake Forest University Health Sciences

This content was sourced from clinicaltrials.gov

Similar Clinical Trials